Lineage Cell Therapeutics Inc
TASE:LCTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
US |
|
Inspecs Group PLC
LSE:SPEC
|
UK |
|
Cheniere Energy Inc
NYSE:LNG
|
US |
|
Stewart Information Services Corp
NYSE:STC
|
US |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
JP |
|
Extreme Networks Inc
NASDAQ:EXTR
|
US |
|
Acuren Corp
NYSE:TIC
|
US |
|
Imricor Medical Systems Inc
ASX:IMR
|
US |
|
ContextVision AB
OSE:CONTX
|
SE |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
CapitaLand Ascott Trust
SGX:HMN
|
SG |
|
Artisanal Spirits Company PLC
LSE:ART
|
UK |
|
United Fire Group Inc
NASDAQ:UFCS
|
US |
Shareholder Yield
Current shareholder yield for LCTX is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
LCTX Price
Lineage Cell Therapeutics Inc
| Average Annual Return | -26.17% |
| Standard Deviation of Annual Returns | 27.02% |
| Max Drawdown | -100% |
| Market Capitalization | 280.8m ILS |
| Shares Outstanding | 790 772 |
| Percentage of Shares Shorted |
N/A
|
